Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaohui Tao

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Biochemical Pharmacology|July 22, 2023
The role of sclerostin in lipid and glucose metabolism disordersHewen Jiang, Dijie Li, Ying Han, et al.
JACS Au|December 26, 2025
Harnessing Bone-Liver Crosstalk: A Dual-Action LYTAC Approach for Bone-Specific Accumulation and Liver-Specific Protein Degradation in Bone DisordersYuan Ma, Gubu Amu, Yufei Pan, et al.
Bone Research|April 24, 2026
Osteoblastic sclerostin loop3-LRP4 interaction required by sclerostin to inhibit bone formationLuyao Wang, Xiaohui Tao, Hewen Jiang, et al.
Cell Reports. Medicine|April 24, 2026
Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancerMeiheng Sun, Hang Luo, Shuangying Qiao, et al.
Journal of Orthopaedic Translation|June 15, 2026
Blocking interaction of sclerostin loop3 with osteoblastic LRP4 counteracts bone loss without increasing arterial stiffness during mechanical unloadingLuyao Wang, Ning Zhang, Hewen Jiang, et al.
Nature Communications|January 16, 2026
Adipocytic sclerostin loop3-LRP4 interaction required by sclerostin to impair whole-body lipid and glucose metabolismHewen Jiang, Xiaohui Tao, Sifan Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 24, 2025
Macrophagic Sclerostin Loop2-ApoER2 Interaction Required by Sclerostin for Cardiovascular Protective ActionLuyao Wang, Xiaohui Tao, Ning Zhang, et al.
Nature Communications|October 3, 2024
Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesityChuanxin Zhong, Nanxi Li, Shengzheng Wang, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Biochemical Pharmacology|July 22, 2023
The role of sclerostin in lipid and glucose metabolism disordersHewen Jiang, Dijie Li, Ying Han, et al.
JACS Au|December 26, 2025
Harnessing Bone-Liver Crosstalk: A Dual-Action LYTAC Approach for Bone-Specific Accumulation and Liver-Specific Protein Degradation in Bone DisordersYuan Ma, Gubu Amu, Yufei Pan, et al.
Bone Research|April 24, 2026
Osteoblastic sclerostin loop3-LRP4 interaction required by sclerostin to inhibit bone formationLuyao Wang, Xiaohui Tao, Hewen Jiang, et al.
Cell Reports. Medicine|April 24, 2026
Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancerMeiheng Sun, Hang Luo, Shuangying Qiao, et al.
Journal of Orthopaedic Translation|June 15, 2026
Blocking interaction of sclerostin loop3 with osteoblastic LRP4 counteracts bone loss without increasing arterial stiffness during mechanical unloadingLuyao Wang, Ning Zhang, Hewen Jiang, et al.
Nature Communications|January 16, 2026
Adipocytic sclerostin loop3-LRP4 interaction required by sclerostin to impair whole-body lipid and glucose metabolismHewen Jiang, Xiaohui Tao, Sifan Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 24, 2025
Macrophagic Sclerostin Loop2-ApoER2 Interaction Required by Sclerostin for Cardiovascular Protective ActionLuyao Wang, Xiaohui Tao, Ning Zhang, et al.
Nature Communications|October 3, 2024
Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesityChuanxin Zhong, Nanxi Li, Shengzheng Wang, et al.
Pageof 5